667, L.P.
Director; Director, 10% Owner · 22 filings · Latest: Sep 30, 2026
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Kodiak Sciences Inc.
Kymera Therapeutics, Inc.
MADRIGAL PHARMACEUTICALS, INC.
Prelude Therapeutics Inc
Replimune Group, Inc.
TScan Therapeutics, Inc.
vTv Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KOD | 667, L.P. | Director, 10% Owner | Sep 29, 2026 | Purchase | $85.05 | 33,726 | $2.9M | 20,191,214 | |
KOD | 667, L.P. | Director, 10% Owner | Sep 28, 2026 | Purchase | $88.77 | 681,866 | $60.5M | 20,159,386 | |
KOD | 667, L.P. | Director, 10% Owner | Sep 28, 2026 | Purchase | $83.58 | 418,323 | $35.0M | 19,515,907 | |
KOD | 667, L.P. | Director, 10% Owner | Sep 28, 2026 | Purchase | $72.57 | 807,840 | $58.6M | 19,121,134 | |
CELC | 667, L.P. | — | Jul 14, 2026 | Proposed Sale | $102.50 | 261,368 | $26.8M | — | |
ONC | 667, L.P. | Director | May 22, 2026 | Sale | $23.82 | 10,998 | $262.0K | 142,570 | |
INCY | 667, L.P. | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |
TARA | 667, L.P. | — | Apr 23, 2026 | Proposed Sale | $5.35 | 24,802 | $132.7K | — | |
TARA | 667, L.P. | — | Mar 6, 2026 | Proposed Sale | $5.85 | 38,277 | $223.9K | — | |
TARA | 667, L.P. | — | Mar 4, 2026 | Proposed Sale | $6.26 | 35,173 | $220.2K | — | |
TARA | 667, L.P. | — | Feb 25, 2026 | Proposed Sale | $5.81 | 78,716 | $457.0K | — | |
TARA | 667, L.P. | — | Feb 24, 2026 | Proposed Sale | $6.04 | 26,755 | $161.6K | — | |
ONC | 667, L.P. | — | Feb 28, 2025 | Proposed Sale | $260.00 | 60,851 | $15.8M | — | |
ONC | 667, L.P. | — | Dec 9, 2024 | Proposed Sale | $187.27 | 86,110 | $16.1M | — |